REGENCOV Trademark

Trademark Overview


On Tuesday, October 27, 2020, a trademark application was filed for REGENCOV with the United States Patent and Trademark Office. The USPTO has given the REGENCOV trademark a serial number of 90282663. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 19, 2022. This trademark is owned by Regeneron Pharmaceuticals, Inc.. The REGENCOV trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders
regencov

General Information


Serial Number90282663
Word MarkREGENCOV
Filing DateTuesday, October 27, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 19, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 22, 2020

Trademark Statements


Goods and ServicesPharmaceutical preparations for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders; antivirals for treatment or prevention of COVID-19, coronavirus disease, and respiratory diseases and disorders

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, November 17, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameRegeneron Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Party NameRegeneron Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591

Trademark Events


Event DateEvent Description
Monday, September 19, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, September 19, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 14, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, July 14, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, July 14, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, January 14, 2022SOU EXTENSION 2 GRANTED
Friday, January 14, 2022SOU EXTENSION 2 FILED
Friday, January 14, 2022TEAS EXTENSION RECEIVED
Tuesday, July 20, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, July 16, 2021SOU EXTENSION 1 GRANTED
Friday, July 16, 2021SOU EXTENSION 1 FILED
Friday, July 16, 2021TEAS EXTENSION RECEIVED
Tuesday, February 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 22, 2020PUBLISHED FOR OPPOSITION
Wednesday, December 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 17, 2020ASSIGNED TO EXAMINER
Tuesday, November 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 16, 2020PETITION TO DIRECTOR - GRANTED
Thursday, November 12, 2020ASSIGNED TO PETITION STAFF
Monday, November 2, 2020TEAS PETITION TO DIRECTOR RECEIVED
Friday, October 30, 2020NEW APPLICATION ENTERED IN TRAM